Oral microbial shift induced by probiotic Bacillus coagualans along with its clinical perspectives.
Study Design
- Тип исследования
- Review
- Популяция
- None
- Вмешательство
- Oral microbial shift induced by probiotic Bacillus coagualans along with its clinical perspectives. None
- Препарат сравнения
- None
- Первичный исход
- colitis/IBD severity
- Направление эффекта
- Positive
- Риск систематической ошибки
- Unclear
Abstract
When used in adequate amounts, Probiotics are considered to beneficially affect host health in many respects. Bacillus coagulans, with its probiotic characteristics, has recently attracted the attention of many researchers and food manufacturers due to its high tolerance in extreme environments because of its spore-forming nature. Several beneficial effects of B. coagulans have been estimated as it exhibits properties of both the genera Bacillus as well as Lactobacillus. Recent literature has proven that B. coagulans has therapeutic effects on intestinal diseases including acute diarrhea, irritable bowel syndrome, antibiotic-related diarrhea, constipation, and colitis via modulation of the microbial composition, host immunity, and general metabolism. Due to the evidence supporting various probiotic effects of B. coagulans, the administration of many B. coagulans strains has been studied in the prevention and management of several oral diseases and conditions. The current review summarizes the probiotic characteristics and clinical, microbiological changes associated with the application of B. coagulans in oral health and diseases along with its future perspectives.
Кратко
The current review summarizes the probiotic characteristics and clinical, microbiological changes associated with the application of B. coagulans in oral health and diseases along with its future perspectives.
Used In Evidence Reviews
Similar Papers
Food & nutrition research · 2018
Bacillus coagulans MTCC 5856 for the management of major depression with irritable bowel syndrome: a randomised, double-blind, placebo controlled, multi-centre, pilot clinical study.
Postgraduate medicine · 2009
Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS.
Methods and findings in experimental and clinical pharmacology · 2009
Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome.
Nutrition journal · 2016
Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study.
Scientific reports · 2019
Randomized clinical trial: the effect of probiotic Bacillus coagulans Unique IS2 vs. placebo on the symptoms management of irritable bowel syndrome in adults.
Beneficial microbes · 2018